Close Menu

Considering that there are now 4,000 to 5,000 tests for heritable conditions, the question of how good is any test if it doesn't lead to actionable results is on the mind of a lot of people in the consumer genetic testing industry. Scripps' Eric Topol is conducting an experiment to see if taking a test (in this case, they're using Navigenics) will spur people to actually improve their lifestyles. Most experts still urge caution. If you're not taking the test under genetic counseling supervision, you might as well skip it, says one.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.